Skip to content
Parkinson's News Today logo Newsletter
Newsletter
  • About Parkinson's
    What is Parkinson’s disease?
    Causes
    Diagnosis
    Symptoms
    • Motor symptoms
    • Non-motor symptoms
    Living with Parkinson’s
    Types
    Treatments
    • Approved treatments
    • Experimental treatments
    • Non-drug treatments
  • Expert voices
    Integrative medicine
    Deep brain stimulation
    Safe exercise
    Cannabis and Parkinson’s symptoms
    Speech difficulties
    Diet and nutrition
    Caring for mental health
    Managing sex and intimacy issues
  • Parkinson's psychosis guide
    Patients
    • What is psychosis?
    • Talking to your doctor about psychosis
    • Perspective: Living with psychosis
    • Emotional and mental health
    • Psychosis risk factors
    Caregivers of spouses
    • Early signs of psychosis
    • Preparing for psychosis
    • Perspective: Supporting your spouse
    • Respite care
    • Hallucinations, delusions, illusions
    Caregivers of parents
    • Talking to a parent with psychosis
    • Psychosis care options
    • Perspective: Caring for a parent
    • Do’s and don’ts
    • Remote Parkinson’s care
    In focus video series
    • Managing Parkinson’s psychosis
    • Strategies for managing psychosis
    • Early signs of psychosis
    • Discerning Parkinson's-related psychosis
  • News
  • Columns
    The Bright Side – Jamie Askari
    Living My Best Life – Christine Scheer
    The Love Factor – Chukwuemeka Uchebuakor
    PD: The WE Journey – Jill Hammergren
    The Impatient Patient – Doc Irish
    Shaking Things Up — Mary Beth Skylis
    Unshakable Optimist – Mollie Lombardi
    Archived columns
    • Embrace the Shake — Samantha Felder
    • Life, Lemons, and Lemonade — Lori DePorter
    • Possibilities With Parkinson’s — Dr. C
    • Resilient: Living Relentlessly — Jo Gambosi
  • Forums
  • Advocacy partners
  • What can we help you find today?

March 15, 2018 News by Ana Pena, PhD

Better Biomarkers Needed to Diagnose, Predict Risk of Mild Cognitive Impairment

There still are no reliable biomarkers for early detection, or to characterize and predict risk of dementia, in Parkinson’s disease, according to a recent analysis. Several studies on the cognitive deficits, progression to dementia, potential biomarkers and the mechanisms underlying Parkinson’s disease mild cognitive impairment (PD-MCI)…

June 1, 2017 News by Janet Stewart, MSc

Antipsychotics to Treat Parkinson’s Psychosis Need Further Research, Report Says

The antipsychotics Clozaril (clozapine, or CLZ) and Nuplazid (pimavanserin, or PIM) are potential treatments for Parkinson’s disease psychosis (PDP) in patients with idiopathic Parkinson’s disease (iPD), whose cause is unknown. However, their use is currently limited and further research is necessary, according to…

Recent Posts

  • How I get the most out of my deep brain stimulator
  • Distinct immune responses may detect Parkinson’s before symptoms
  • Protecting the babies inspires me to move like a ninja
  • PMD Alliance seeking participants for survey on Parkinson’s off time
  • Home care agency receives award for work in Parkinson’s, dementia


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: info@bionews.com
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.